1. Home
  2. MYND vs ATNM Comparison

MYND vs ATNM Comparison

Compare MYND & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYND
  • ATNM
  • Stock Information
  • Founded
  • MYND 1998
  • ATNM 2000
  • Country
  • MYND Cayman Islands
  • ATNM United States
  • Employees
  • MYND N/A
  • ATNM N/A
  • Industry
  • MYND Other Consumer Services
  • ATNM Biotechnology: Pharmaceutical Preparations
  • Sector
  • MYND Real Estate
  • ATNM Health Care
  • Exchange
  • MYND Nasdaq
  • ATNM Nasdaq
  • Market Cap
  • MYND 38.8M
  • ATNM 46.5M
  • IPO Year
  • MYND 2017
  • ATNM N/A
  • Fundamental
  • Price
  • MYND $0.85
  • ATNM $1.55
  • Analyst Decision
  • MYND
  • ATNM Strong Buy
  • Analyst Count
  • MYND 0
  • ATNM 4
  • Target Price
  • MYND N/A
  • ATNM $8.75
  • AVG Volume (30 Days)
  • MYND 16.5K
  • ATNM 1.4M
  • Earning Date
  • MYND 04-08-2025
  • ATNM 04-25-2025
  • Dividend Yield
  • MYND N/A
  • ATNM N/A
  • EPS Growth
  • MYND N/A
  • ATNM N/A
  • EPS
  • MYND N/A
  • ATNM N/A
  • Revenue
  • MYND $267,380,999.00
  • ATNM N/A
  • Revenue This Year
  • MYND N/A
  • ATNM N/A
  • Revenue Next Year
  • MYND N/A
  • ATNM N/A
  • P/E Ratio
  • MYND N/A
  • ATNM N/A
  • Revenue Growth
  • MYND N/A
  • ATNM N/A
  • 52 Week Low
  • MYND $0.61
  • ATNM $1.03
  • 52 Week High
  • MYND $4.69
  • ATNM $10.24
  • Technical
  • Relative Strength Index (RSI)
  • MYND 33.54
  • ATNM 55.97
  • Support Level
  • MYND $0.84
  • ATNM $1.41
  • Resistance Level
  • MYND $0.90
  • ATNM $2.41
  • Average True Range (ATR)
  • MYND 0.08
  • ATNM 0.24
  • MACD
  • MYND 0.01
  • ATNM 0.01
  • Stochastic Oscillator
  • MYND 5.88
  • ATNM 30.80

About MYND Mynd.ai Inc.

Mynd.ai Inc is a company that provides a platform for delivering digital content in K-12 classrooms, giving teachers seamless connectivity to inspire young minds. It features agnostic hardware that integrates across technology providers. Its product line includes a wide range of interactive tools and technologies, with its award-winning interactive displays at the forefront. It also offers interactive software apps such as Screen Share, computing modules, and accessories that meet the needs of customers, including K -12 educators, colleges and universities, small businesses and corporations, government agencies, and more.

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

Share on Social Networks: